EKSPRESI HIF-1α PADA KANKER OVARIUM EPITELIAL: PERDEDAAN ANTARA KASUS DENGAN ENDOMETRIOSIS DAN TANPA ENDOMETRIOSIS
DOI:
https://doi.org/10.59003/nhj.v5i6.1733Keywords:
Epithelial ovarian cancer, endometriosis, EAOC, non-EAOC, HIF-1αAbstract
Ovarian cancer is a cancer that grows in the ovaries where epithelial ovarian carcinoma is the most common type. Endometriosis is one of the risk factors for ovarian cancer. Understanding the microenvironment and mechanisms of endometriosis-related ovarian cancer carcinogenesis is needed to improve treatment and patient prognosis. Hypoxia is one of the microenvironments in endometriosis that can promote ovarian cancer through HIF-1α activation. HIF-1α activation can induce target genes involved in carcinogenesis and other intracellular signaling pathways. Research on HIF-1α with endometriosis-related ovarian cancer is still very limited and no one has compared it between groups with endometriosis and groups without endometriosis. This study aims to determine the differences in HIF-1α expression in epithelial ovarian cancer with endometriosis (EAOC) and without endometriosis (non-EAOC). The design of this observational analytical study with a cross-sectional design. The population of this study was all cases of epithelial ovarian cancer diagnosed in the Anatomic Pathology Laboratory of M. Djamil Padang Hospital from January 2024 to June 2025. A total of 34 cases of epithelial ovarian cancer were sampled, with a proportion of 17 EAOC cases and 17 non-EAOC cases taken by consecutive sampling. Slides that had been stained with hematoxyline and eosine (HE) were reevaluated for classification, type, grading, and staging. Paraffin blocks were collected for further HIF-1α immunohistochemistry (IHK) examination to analyze protein expression semiquantitatively (Immunoreactivity score). High HIF-1α expression was considered if the IRS score was 4-12. Statistical data analysis used the Chi-square test. Results: The results of the study found that the majority of EAOC patients were aged 41-50 years with an average age of 45 years, the most common parity status was multiparous, the most common type of endometriosis was endometriotic cyst (endometrioma), the most common histopathological type was type I, the most common histopathological grade was high grade, and the most common stage was early stage. There was no significant difference between HIF-1α expression in EAOC and non-EAOC (p = 1.000), as well as staging (p = 0.086). However, there was a significant relationship between HIF-1α expression and histopathological type (p = 0.034) and grading (p = 0.001) of epithelial ovarian cancer. High HIF-1α expression plays a greater role in the progression and aggressiveness of epithelial ovarian cancer, while its role in tumorigenesis and carcinogenesis still requires further research.
Downloads
References
Asther et al. WHO classification of tumours online. female genital tumours (5th edition). endometriosis and related conditions// endometriosis and derived tumours. international agency for research on cancer. 2025.
Huang et al. Worldwide burden, risk factors, and temporal trends of ovarian cancer: a global study. cancers. 2022.
Cabasag et al. ovarian cancer today and tomorrow: a global assessment by world region and human development index using globocan 2020. int j cancer. 2022.
Kemenkes RI. rencana kanker nasional 2024-2034: strategi indonesia dalam upaya melawan kanker. kementerian kesehatan republik indonesia. 2024.
Badan Registrasi Kanker Perhimpunan Dokter Spesialis Patologi Anatomi. Kanker di indonesia tahun 2011 data histopatologik, direktorat jendral pelayanan medik departemen kesehatan ri, jakarta, yayasan kanker indonesia. 2011.
IJ Rowlands et al. Global epidemiological data on endometriosis. spinger nature link. 2022.
Rahmioglu et al. Endometriosis: disease mechanism and health disparities. bulletin of the WHO. 2024.
Dai et al. Hypoxia and the endometrium: an indispensable role for hif-1α as theurapeutic strategies. redox biology. elsevier. 2024.
Chen et al. Advances in research on malignant transformation of endometriosis-associated ovarian cancer. mini review. frontiers in oncology. 2024.
Asis et al. Research: association hypoxia inducible factors-1 alpha (hif-1α) levels and epithelial ovarian cancet (eoc). indonesian journal of obstetric and gynecology science. makassar. 2023. volume 6 nomor 1.
Lee et al. Over expression of hypoxia-inducible factor 1-alpha in ovarian clear cell carcinoma. gynecologic oncologic. 2007. p311-317.
Varga et al. Research: predictive factors of endometriosis progression into ovarian cancer. journal of ovarian research. 2022. 15:5.
Andreou et al. Prognostic factors influencing survival in ovarian cancer patients: a 10-year retrospective study. cancers. 2023
Chen et al. Review: new insights about endometriosis- associated ovarian cancer: pathogenesis, risk factors, prediction and diagnosis and treatment. frontiers in oncology. 2024.
He et al. Research: predictive factors of ovarian carcinoma for women with endometrioma aged 45 years and older in China. Journal of Ovarian Research. 2017.
Hablase et al. The “road” to malignant transformation from endometriosis to endometriosis-associated ovarian cancer (eaocs): an mtor-centred review. cancers. MDPI. 2024.
Samartzis et al. Endometriosis-Associated Ovarian Carcinoma: Insights into Pathogenesis Diagnostic and Therapeutic Targets-A Narrative Review. Annal of Translational Medicine. 2020.
Barreta et al. Endometriosis-associated ovarian cancer population characteristics and prognosis. international journal of gynecological cancer. 2018. vol 28, No 7.
WHO. Female genital tumours. who classifications of tumours 5th edition. international agency for research on cancer. 2020. volume 4.
Priyanto et al. Analysis of the malignancy risk of endometriosis and ovarian cancer related to endometriosis-associated ovarian cancer: a histopathological review and genetic mutation. research article. journal of south asian federation of obstetric and gynaecology. 2025.
WHO. Endometriosis: world health organization fact-sheets. 2025. available online at https://www.who.int/news-room/fact-sheets/detail/endometriosis.
Hasby et al. Penelitian: Ekspresi Hypoxia Inducible Factor-1α pada Jaringan Endometriosis. Jurnal Kedokteran Universitas Sumatera Utara. 2015.
Pramesti et al. Karakteristik klinikopatologis penderita endometriosis di RSUP Sanglah Denpasar. Jurnal Medika Udayana. 2020.
Hidayat et al. Karakteristik penderita endometriosis dan adenomiosis di rsup dr. m. djamil padang. j obgin emas. 2019.
Aimagambetova et al. Epidemiology of endometrium Kazakhstan: a natural population based cohort analysis (2014-2019) using data from the national health care system. 2025.
Markov et al. Original Article: Expression of hif-1α, ki67, sma and e-cadherin in endometriosis, endometrial and ovarian carcinoma. folia medica. 2024. vol.66, No.1.
Lee et al. Over expression of hypoxia-inducible factor 1-alpha in ovarian clear cell carcinoma. gynecologic oncologic. 2007. p311-317.
Adilbayeva et al. Review: pathogenesis of endometriosis and endometriosis-associated cancers. 2024. international journal of molecular science. MDPI. 25,7624.
Steinbuch et al. Review: endometriosis- associted ovarian cancer: from molecular pathologies to clinical relevance. international journal of molecular science. MDPI. 2024. 25,4306.
Michael et al. Review: endometriosis-associated ovarian cancer: a review of pathogenesis. international journal of molecular science. mdpi. 2013. 14.
Pavaleanu et al. Original Article: Immunohistochemical profile of endometriosis- associated ovarian cancer. research and clinical medicine. 2018. volume ii, issue II.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Rahmi Ramadhani

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
NHJ is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Articles in this journal are Open Access articles published under the Creative Commons CC BY-NC-SA License This license permits use, distribution and reproduction in any medium for non-commercial purposes only, provided the original work and source is properly cited.
Any derivative of the original must be distributed under the same license as the original.





















